Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Slowing Down Stock
5298.0000 -3.50 (-0.07%)
NSE Jun 12, 2026 15:31 PM
Volume: 67,310
 

5298.00
-0.07%
ICICI Securities Limited
Alkem Laboratories’ CEO, Dr. Vikas Gupta, is targeting double-digit revenue growth in the medium term, driven by strong hold in India (68% of sales), other international markets and new ventures.
Number of FII/FPI investors decreased from 613 to 607 in Mar 2026 qtr
More from Alkem Laboratories Ltd.
Recommended